Helga Gardarsdottir

Associate professor

Utrecht University

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (11)

Satu J Siiskonen

Utrecht University

NETHERLANDS

View details

Sharon Essink

Utrecht University

NETHERLANDS

View details

Helle Wallach-Kildemoes

Københavns Universitet

DENMARK

View details

Patrick Souverein

Utrecht University

NETHERLANDS

View details

Christine Hallgreen

Københavns Universitet

DENMARK

View details

Saskia Le Cessie

Leiden University

NETHERLANDS

View details

Tomas Lasys

Utrecht University

NETHERLANDS

View details

Ghislaine van Thiel

Associate professor Medical Ethics

University Medical Center Groningen

NETHERLANDS

View details

Rolf Groenwold

Professor of Clinical Epidemiology

Leiden University Medical Center

NETHERLANDS

View details

Amos de Jong

Utrecht University

NETHERLANDS

View details

Mira Zuidgeest

University Medical Center Utrecht, Utrecht University

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Helga Gardarsdottir

Research Interests

Explore related searches

Contact this professor

Articles (14)

Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018–2021: A Qualitative Analysis of Industry‐Sponsored Post‐Authorization Safety Studies

Real‐World Evidence to Inform Regulatory Decision Making: A Scoping Review

Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review

Which Benefits Can Justify Risks in Research?

Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021

Unintended impact of pharmacovigilance regulatory interventions: A systematic review

Review of studies evaluating effectiveness of risk minimisation measures assessed by the European Medicines Agency between 2016 and 2021

Impact of a Treatment Guide on Intravenous Fluids in Minimising the Risk of Hospital-Acquired Hyponatraemia in Denmark

Direct‐to‐participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers

Prescribing of low‐dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands

The role of Real-World Data and evidence in oncology medicines approved in EU in 2018–2019

Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study

Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov

Impact of regulatory interventions to restrict the combined use of renin–angiotensin system blockers: A Danish nationwide drug utilisation study

Collaborators (11)

Satu J Siiskonen

Sharon Essink

Helle Wallach-Kildemoes

Patrick Souverein

Christine Hallgreen

Saskia Le Cessie

Tomas Lasys

Ghislaine van Thiel

Rolf Groenwold

Amos de Jong

Mira Zuidgeest

Make your next move.